POSTER NO ABSTRACT NUMBER PRESENTER DATE OF PRESENTATION

PP-1

Study of binding interaction by molecular docking between a

lectin from Cerastes cerastes venom Cc-Lec and coagulation

factors IXa and Xa: Elucidation of anti-blood coagulation

mechanism

Chérifi Fatah Thursday, 19 October 2017

PP-2

Molecular docking and binding interaction of a non-toxic 5’-

nucleotidase with inhibitors and platelet agonists: Study of

Structure-function relationship and anti-platelet aggregation

mechanism

Saoud Samah Thursday, 19 October 2017

PP-3Virtual Screening In Discovering New Leads, Inhibitors Of

Topoisomerase Ii Alpha, Purine Derivative AITKAKI Samira Thursday, 19 October 2017

PP-4A search for new topoisomerase II alpha inhibitors, pyrazoline

dérivétive, by virtual screening AITKAKI Samira Thursday, 19 October 2017

PP-5Synthesis and evaluation of the biological activity of chemical

compounds belonging to the class of amidochromenes Neghra Abdelhak Thursday, 19 October 2017

PP-6Aucuboside, Source of compounds with potential biological

activity Neghra Abdelhak Thursday, 19 October 2017

PP-7Identification of HDAC6 selective inhibitors via structure-based

virtual screening and molecular dynamics simulation assayAbdullahi Ibrahim Uba Thursday, 19 October 2017

PP-8

Phytochemical study and evaluation of the bacteriostatic activity

of the essential oil of an aromatic plant: Salvia officinalis L. on

resistant pathogenic germs

Leila Derradji Thursday, 19 October 2017

PP-9Composition, cytotoxic and apoptotic activities of

Angelica Sylvestris L.var sylvestrisAyşe Daut Özdemir Thursday, 19 October 2017

PP-10

IDENTIFICATION OFNEWVIM-SUBFAMILY METALLO-β-

LACTAMASES THIOENOLATESINHIBITORSLEADSFROMVIRTUAL

SCREENING

LAYACHI FAYCAL Thursday, 19 October 2017

PP-11Phytochemical study and the bacteriostatic activity evaluation of

an aromatic plant: Salvia officinalis L. Leila Derradji Thursday, 19 October 2017

PP-12Silver Nanoparticles; Parametric study and modeling by

application of the experimental design methodologyHOUAMRIA Hamza Thursday, 19 October 2017

PP-13In-Silico Design and Discovery of Novel Activators of Adenosine

Monophosphate-Activated Protein Kinase (AMPK) Mariya al-Rashida Thursday, 19 October 2017

PP-14

Validation and application of a colorimetric method for the

determination of nitrates in water intended for human

consumption in Algeria

MEKAHLIA LEILA Thursday, 19 October 2017

PP-15

Interactions of Halogenated Propylthiouracils and

Lactoperoxidase through3D–QSAR Predictions and Molecular

Docking Evaluations

Mahmoud Mirzaei Thursday, 19 October 2017

PP-16Molecular electrostatic potentials and HOMO-LUMO Studies of

Angiotensin-converting enzyme (ACE) inhibitors for hypertensionSyed Mohamed Abubacker Thursday, 19 October 2017

PP-17Preparation and application of biocompatible carrier implant in

Rifampisin sodium controlled release system HESNA URAL KAYALIK Thursday, 19 October 2017

PP-18Novel Chiral Monoamine Oxidase Inhibitors: Molecular Docking

Studies on N-AryloxazolidinedionesNESRİN GÖKHAN KELEKÇİ Thursday, 19 October 2017

PP-19DOCKING AND SCORING IN SEVERAL PDB OFVIM-2 SUBFAMILY

METALLO-β-LACTAMASESLAYACHI FAYCAL Thursday, 19 October 2017

PP-20

Syntheses and Properties of MePEG-Poly(LLA-co-αBrγBL) and

MePEG-Poly(LLA-co-αNBocγBL) Copolymers for Targeted Drug

Delivery Applications

Yonca Colak Thursday, 19 October 2017

PP-21Investigation of the antibacterial activity of new cyanopyridin

derivativesEsra KOC Thursday, 19 October 2017

PP-22Design of Potent Multi-target CAs inhibitors through

Pharmacophore Modeling NUR GÜREL Thursday, 19 October 2017

PP-23Enantioselective 1,3-dipolar Cycloaddition Reactions of

azomethine ylides by using new chiral phosphorous ligandsSerap Mert Thursday, 19 October 2017

PP-24Study of 4’-amino-4-fluorochalcone with cucurbit[7]uril

as anti-inflammatory agents Samia Amirat Thursday, 19 October 2017

PP-25Synthesis and Evaluation of A New Series of Naphthalene-Based

Thiadiazole Derivatives as Potential Anticancer AgentsBelgin Sever Thursday, 19 October 2017

PP-26Design, Synthesis and Evaluation of New Oxadiazole Derivatives

as Potential Akt InhibitorsBelgin Sever Thursday, 19 October 2017

PP-27Synthesis of Cyclohexanetetrolic Compounds with Polyhydroxy

Cyclohexanoid CoreEmel Karakılıç Thursday, 19 October 2017

PP-28 3D-Calixarene Nanofiber Systems for Anticancer Drug Screening Müslüm Ağaç Thursday, 19 October 2017

PP-29Synthesis and Biological Activity of Tetrol Derivatives as

Glycosidase InhibitorsGökay Aydın Thursday, 19 October 2017

PP-30Synthesis and Evaluation of New Pyrrole Derivatives as Selective

Human MAO InhibitorsAhmet Özdemir Thursday, 19 October 2017

PP-31

IRON(III) COMPLEXES BASED ON THIOSEMICARBAZONE:

SYNTHESIS AND CYTOTOXICITY ON LEUKEMIA CELLS WITH

OVERCOME DRUG RESISTANCE

Büşra Kaya Thursday, 19 October 2017

PP-32EFFECTIVE NEW IRON COMPLEXES ON K562 AND HL-60 CELL

LINES Büşra Kaya Thursday, 19 October 2017

PP-33

Superoxide dismutase enzyme activities and anticancer

properties of Cu(II), Ni(II) and Pt(II) complexes derived from 2-

cyanoguanidine

Muhammet Köse Thursday, 19 October 2017

PP-34

4D-QSAR Analysis and Pharmacophore Modeling: Electron

Conformational-Genetic Algorithm Approach for Imidazo

Derivatives

Sevtap Çağlar Yavuz Thursday, 19 October 2017

PP-35Design, Synthesis and Evaluation of New Pyrazoline Derivatives as

Potential Anticandidal AgentsMehlika Dilek Altıntop Thursday, 19 October 2017

PP-36Computational Design, Synthesis and Antituberculosis Activity of

Novel Modified Fluoroquinolone DerivativesAslı Demirci Thursday, 19 October 2017

PP-37

A Hybrid Approach for the Design, Synthesis and Anticancer

Activity of Phenylaminopyrimidine Core Containing 2-Imino-4-

thiazolidinone Derivatives

Aslı Demirci Thursday, 19 October 2017

PP-38 Anticancer Activities of New Compounds that Include Anthracene Senem Akkoç Thursday, 19 October 2017

PP-39Synthesis and Characterization of Biologically Important Organic

CompoundsSenem Akkoç Thursday, 19 October 2017

PP-40Steered Molecular Dynamics Simulation for Efficient Ranking of

Peptide - MHC Class I Binding AffinitiesOnur Serçinoğlu Thursday, 19 October 2017

PP-41

COMPUTATIONAL ASSESSMENT OF ALLOSTERIC MUTATIONS ON

THE DYNAMICS OF PDZ DOMAINS AS POTENTIAL THERAPEUTIC

TARGETS

Nazlı Kocatuğ Thursday, 19 October 2017

PP-42Snythesis and Characterization of Bis(oxime) Based Transition

Metal Complexes Targeting Human Topoisomerase IRamazan GUP Thursday, 19 October 2017

PP-43 Development of New Lead BACE1 Enzyme Inhibitors Gözde Yalçın Thursday, 19 October 2017

PP-44Design of High-affinity PARP-2 Inhibitors by Dynamic Structure-

Based Pharmacophore ApproachMehdi Meran Thursday, 19 October 2017

PP-45Blue Luminescing Iron Oxide Nanoparticles for Gene and Drug

Delivery ApplicationsÖzlem Ünal Thursday, 19 October 2017

PP-46

Calculation of Protein Mutability Landscape and Thereon

Forecasting Evolutionary Pathways: Neuraminidase of H1N1 Virus

as a Case Study

Elif Candaş Thursday, 19 October 2017

PP-47Cytotoxic Activity of Lobothallia radiosa (Hoffm.) Hafellner in

Human MCF-7 Breast Cancer CellsHatice Esra Akgül Thursday, 19 October 2017

PP-48

Analysis of Protein-Ligand Interaction via Homology Modeling,

Docking and Molecular Dynamics Techniques: Neuraminidase

Protein (H1N1 influenza virus) as a Case Study

Gizem Gökçe Thursday, 19 October 2017

PP-49 Modeling and Design of Controlled Drug Release Systems Mervenaz Şahin Thursday, 19 October 2017

PP-50 Synthesis and Structure of Indole-BODIPY Gökay AYDIN Thursday, 19 October 2017

PP-51The effect of Diltiazem and Verapamil on Cytosolic Enzymes: Old

Drugs New TricksS. Belgin İşgör Thursday, 19 October 2017

PP-52 Biomedical Applications of Electrospun Pembegül Uyar Arpacı Thursday, 19 October 2017

PP-53The Effect of Beta-Blocker Drugs on Primary Antioxidant Defense

EnzymesYasemin G. İşgör Thursday, 19 October 2017

PP-54Detection of the allosteric residue network in effector caspase

molecules by energy dissipation modelElif Naz BINGOL Thursday, 19 October 2017

PP-55A Study on Anticancer Activity of Calixarene

on Human Osteosarcoma Saos-2 CellsEsin Şirin Thursday, 19 October 2017

PP-56Preparation of dry powder inhaler formulation of triamcinolone

acetonide using turbula mixer for pulmonary drug deliveryAysu Yurdasiper Erdem Thursday, 19 October 2017

PP-57Effect of leucine on aerosol performance of dry powder inhaler

formulationsAysu Yurdasiper Erdem Thursday, 19 October 2017

PP-58Enantioselective 1,3-Dipolar Cycloaddition Reactions of

Azomethine Ylides by Using New Chiral Phosphorous LigandsSerap Mert Thursday, 19 October 2017

PP-59Molecular docking analyses of coumarin derivatives as Theileria

annulata enolase inhibitorsSinem Yakarsonmez Thursday, 19 October 2017

PP-60Comparison of ionic polymers in the targeted drug delivery

agents as the coating materials Maide Gökçe Bekaroğlu Thursday, 19 October 2017

PP-61Synthesis of Cyclohexanetetrolic Compounds with Polyhydroxy

Cyclohexanoid CoreEmel KARAKILIÇ Thursday, 19 October 2017

PP-62

Comparative Proteomic Analysis of Antiproliferative and

Apoptotic Effect of Progesterone in U87MG and A172

Glioblastoma Cells

Muazzez Ceren YILMAZ Thursday, 19 October 2017

PP-63Podophyllotoxin-procainamide conjugate as a novel anti

Condyloma acuminata agentFatemeh Moradkhani Thursday, 19 October 2017

PP-64

Investigation of the Effects of 5-Fluoruracil and Temozolomide

Combinations on Cell Survival in SKBR3 Human Breast Cancer Cell

Line

Onur EROĞLU Thursday, 19 October 2017

PP-65Comparative effects of monotherapy and polytherapy with CAPE

and Cisplatin on SKBR3 Breast cancer cell line Esin GÜVENİR ÇELİK Thursday, 19 October 2017

PP-66Identification of Clock-modifying Small Molecules Modulating

CLOCK and BMAL1 HeterodimerizationDarya Yarparvar Thursday, 19 October 2017

PP-67Discovery of Cryptochrome Destabilizer Small Molecules

Enhancing the Apoptosis Şeref Gül Thursday, 19 October 2017

PP-68A QSAR and Docking Study of Sulfonamide Derivatives as

Carbonic Anhydrase (CA XII Isozyme) InhibitorErol Eroğlu Thursday, 19 October 2017

PP-69Computational Activity and Target Prediction for Three Novel

Triazolothiadiazine Derivatives Birsen Tozkoparan Köprücü Thursday, 19 October 2017

PP-70

Computational Study on Controlled Release of Anti-Inflammatory

Steroids from Mesoporous Metal-Organic Framework, MIL-

101(Cr)

MERVE AYVAZ KÖROĞLU Thursday, 19 October 2017

PP-71Scanning resistance conferring mutants of DHFR to specify drugs

optimizing inhibitionTandac Furkan Guclu Thursday, 19 October 2017

PP-72Anti-proliferation activity of Tandospirone analogues in tumor

cell linesÖmer Tahir Günkara Thursday, 19 October 2017

PP-73 Grafting of a Cancer Targeting Peptide Epitope onto Cyclotides Şeyda Kara Friday, 20 October 2017

PP-74Synthesis of Hydrazino-Pyrimidine Derivatives by Multi-

Component Reactions Sevtap ÇAĞLAR YAVUZ Friday, 20 October 2017

PP-75Reaction of N (aminoamidino) thiourea derivatives with

dimethylacetylene dicarboxylateIhab AL-JANABI Friday, 20 October 2017

PP-76Cytotoxic activities of Ru-Benzimidazole Complexes to PC-3

Prostate Cancer Cells Serap Şahin Bölükbaşı Friday, 20 October 2017

PP-77Antiproliferative Activity of Gypsogenin to Prostate and Breast

Cancer CellsSerap Şahin Bölükbaşı Friday, 20 October 2017

PP-78The most important element in drug research&development:

Stability study for dexketoprofen trometamol loaded SLNsA. Alper Öztürk Friday, 20 October 2017

PP-79Dissolution and Cyctotoxity Profiles of Quercetin/Rutin

Incorporated β-Cyclodextrin ComplexesA. Alper Öztürk Friday, 20 October 2017

PP-80Synthesis, Characterization, and Properties of PEG Based

Poly(Izobutyl Methyl Glycolide) CopolymersDuygu Çetin Friday, 20 October 2017

PP-81SYNTHESIS OF RU(II) ARENE COMPLEXES AND ANTICANCER

ACTIVITIESHayati Türkmen Friday, 20 October 2017

PP-82 Residue Packing at the Interfaces of Protein Complexes Rasim Murat AYDINKAL Friday, 20 October 2017

PP-83Pharmacological activity of the extracts produced by cultured

lichen mycobionts II ; Inhibition of melanin productionHaruka Yamaguchi Friday, 20 October 2017

PP-84

Synthesis and some biological evaluation of novel heterocycles

bearing indole/pyrrolidine ring system and/or aminocarbothiol

moiety

Samet Poyraz Friday, 20 October 2017

PP-85Synthesis and Biological Evaluation of Pyrrolidine-Thiazoles /

Indole Ring System Containing HetereocyclesSamet Poyraz Friday, 20 October 2017

PP-86Antioxidant Properties of Monoimine and Bisimine Schiff Bases of

Derived from 3,4-Diaminobenzophenone Yeliz KAYA Friday, 20 October 2017

PP-87New Asymmetric Bisthiocarbohydrazone Schiff Bases: Synthesis,

Characterization and Antioxidant Properties Yeliz KAYA Friday, 20 October 2017

PP-88Pharmacological activity of the extracts produced by cultured

lichen mycobionts I ; Anti-bacterial activityHiroko Kawakami Friday, 20 October 2017

PP-89 Interactions of a New Thiazol Derivative with Biomolecules Esra Maltas Cagil Friday, 20 October 2017

PP-90Production, Purification and Characterization of EPO as a Medical

Biotechnological Product Duygu Düzgün Friday, 20 October 2017

PP-91Title of the Abstract : (Use of medicinal plants by cancer patients

in the North East Algerian as an adjunct)Saïdi Ouided Friday, 20 October 2017

PP-92Rationally designing the pi-class glutathione inhihibitors

and synthesis by an eco-friendly method Bnar Jalal Muhammed Friday, 20 October 2017

PP-93Molecular Dynamics Simulations of a Biocompatible Drug

NanoCarrier Pelin Deniz Akkus Friday, 20 October 2017

PP-94Optimization of CXCL2 Gene Expression in Rat Renal Ischemia-

Reperfusion InjurySeyma Hande TEKARSLAN-SAHIN Friday, 20 October 2017

PP-95Non-selective COX-1/COX-2 Inhibition of 3(2H)-Pyridazinone

Derivatives: A Molecular Modelling StudySuat SARI Friday, 20 October 2017

PP-96Spectroscopic and electrochemical properties of the hybrid

materials based on Anderson polyoxometalateMehmet TÜMER Friday, 20 October 2017

PP-97Biological evaluation of the hybrid compounds obtained from the

Keggin POM and diamino anthracene dioneSeyit Ali Güngör Friday, 20 October 2017

PP-98Exploring Functional Dynamics of the Human Ribosomal Structure

using Elastic Network Model and Molecular Dynamics SimulationsPelin Guzel Friday, 20 October 2017

PP-99

Molecular docking, molecular dynamic simulation and free

energy calculation studies of protein-ligand interactions on IRE-

JNK pathway of Drugs acting on the cardiovascular system

Zekeriya DUZGUN Friday, 20 October 2017

PP-100Role of BIP-SBDα subdomain to bind IRE1α: A coarse-grained

molecular dynamic simulation and Free energy calculation studyZekeriya DUZGUN Friday, 20 October 2017

PP-101Fabrication of Novel PEG based PDIBG Nanomaterials for Use of

Drug Delivery SystemsOlcay Mert Friday, 20 October 2017

PP-102

3D-QSAR Analysis of 4-Oxo-1,4-dihydroquinoline and 4-Oxo-4H-

pyrido[1,2-a]pyrimidine Derivatives as Anti-HIV Agents by CoMFA

and CoMSIA

Zahra Hajimahdi Friday, 20 October 2017

PP-103 Gold Substituted Schiff Bases Complexes Nihal Deligonul Friday, 20 October 2017

PP-104Insighit to Understand Acetylcholinesterase Inhibitors:

computational modeling approaches Érica Cristina Moreno Nascimento Friday, 20 October 2017

PP-105

New Pt(II) complexes containing 5-pyrimidinylferrocene:

Synthesis, characterization and DNA binding abilities GÜLCE TAŞKOR Friday, 20 October 2017

PP-106An Alternative Production Method for Collagen to Obtain

ScaffoldsMurat Kazanci Friday, 20 October 2017

PP-107New Synthesis of Asymmetric Diimine Schiff Base for the

Development of DNA Targeted Anticancer DrugZehra Kübra YILMAZ Friday, 20 October 2017

PP-108The protein structure of the PATZ1 BTB domain reveals new

functions Sofia Piepoli Friday, 20 October 2017

PP-109 Synthesis of Novel Coumarin-Sulfonamide Hybrid Derivatives Belma Zengin Kurt Friday, 20 October 2017

PP-110Imine conjugated aza – BODIPY synthesis as fluorescent

chemosensor for cysteine and homocysteine in aqueous mediaBleda Can Sadıkoğulları Friday, 20 October 2017

PP-111Immunogenic Peptide - HLA-A*02:01 Complexes Studied by

Comparative Molecular Dynamics SimulationAsuman Bunsuz Friday, 20 October 2017

PP-112 PVA coated SPIONs as targeted drug delivery agents ARİFE KUŞBAZ Friday, 20 October 2017

PP-113

Colloidal properties and interactions of chitosan coated SPIONs

with liposome layer by QCM-D technique for targeted drug

delivery

ARİFE KUŞBAZ Friday, 20 October 2017

PP-114Flexible Docking and Molecular Dynamic Simulations of Selected

Virtual Biotransformation Reaction Products on IKKβISMAIL HAKKI AKGUN Friday, 20 October 2017

PP-115 Motility Studies by Using Microfluidic Technology Merve Yüce Friday, 20 October 2017

PP-116Evaluation of Antiproliferative Activities of

Water Soluble Supramolecular p-tert-butylcalix[4]areneZuhair Mohammed Friday, 20 October 2017

PP-117

Docking studies of novel structures generated by unusual

fragments to inhibitor of nuclear factor kappa-B kinase subunit

beta.

TURGUT MESUT YILMAZ Friday, 20 October 2017

PP-118In silico Analyses of both Wild Type and Mutant TaPIN1towards

New Drug DiscoverySinem Yakarsonmez Friday, 20 October 2017

PP-119Computational Analysis of AT1R-CB1R Heterodimerization Using

Multiscale Molecular Modeling ApproachesIsik Kantarcioglu Friday, 20 October 2017

PP-120Adsorptive Removal of Paracetamol from Aqeous Solutions by

Three Different Amberlite Resins Ebru Kurtulbaş Friday, 20 October 2017

PP-121Computational Insights into Angiotensin II Type 1 Receptor

(AT1R) DimerizationIsmail Erol Friday, 20 October 2017

PP-122Synthesis of Ruthenium Complexes and Their Anticancer

ActivitiesHayati Türkmen Friday, 20 October 2017

PP-123Advancing affinity and binding site predictions of free energy

methods with model systems Mehtap Işık Friday, 20 October 2017

PP-124Design, Synthesis and Evaluation of A New Series of Donepezil-

Like Chalcone Derivatives as Potential AChE InhibitorsMehlika Dilek Altıntop Friday, 20 October 2017

PP-125Insights into the Molecular Basis of Action of Anti-Hypertensive

Oxazolone and Imidazolone DerivativesBusecan Aksoydan Friday, 20 October 2017

PP-126Toxicity of Gypsogenin Anhydride to Breast and Prostate Cancer

Cells Ayça TAŞ Friday, 20 October 2017

PP-127 A Molecular Docking Study on O-Acetylpeptidoglucan Esterase Fethiye Aylin Sungur Friday, 20 October 2017

PP-128hERG1 Channel Interaction with Scorpion Toxins: Using MM-PBSA

calculations to describe in-silico binding resultsBeril Çolak Günay Friday, 20 October 2017

PP-129

Identification of Novel MDM2-p53 Protein-Protein Interaction

Inhibitors as New Anticancer Hits: Combined Molecular Docking,

ADME/Tox, MetaCore and MetaDrug Study

Gülşah Aydın Friday, 20 October 2017

PP-130Surface Modified Supramolecular p-tert-butylcalix[4]arene:

New Opportunities for Anticancer Drug DevelopmentKübra Çini Friday, 20 October 2017

PP-131Complex Synthesis of Phthalocyanine from Anti-HIV agent 1,3

Phosphorothioate DerivativeArif Baran Friday, 20 October 2017

PP-132Real-time Cell Analysis of the Inhibitory Effect of

Calixarene on Adhesion and Proliferation of Breast Cancer CellsEmine Gök Friday, 20 October 2017

PP-133In Vitro Cytotoxicity of Multiwalled Carbon Nanotubes as Protein

Nanocarriers Bircan DINC Friday, 20 October 2017

PP-134Elimination of Naproxen from Wastewaters with Various

Polymeric ResinsEbru Kurtulbaş Friday, 20 October 2017

PP-135Potency of interleukin 8 blockade in prevention of liver cancer

stem cell enrichmentDeniz Cansen Kahraman Friday, 20 October 2017

PP-136 Exploring the Structure and Proton Affinities of various b3+ Ions Seçkin Boz Friday, 20 October 2017

PP-137 Anticancer Activity of Isoeugenol-Based Phenolic Compounds Esra KOC Friday, 20 October 2017

PP-138

Interactions and Biological Evaluation of the complexed

Candesartan and its prodrug Candesartan Cilexitine in

Cyclodextrin with lipid bilayers

Sofia Kiriakidi Friday, 20 October 2017

PP-139

Design of Novel Compounds from Prunella Vulgaris, Cannabis

Sativa and Withania Somnifera for their Therapeutical Profiles

Against Rheumatoid Arthritis Using Structure-Based

Pharmacophore (E-Pharmacophore) and Ligand-Based

Pharmacophore Modeling

Mehreen Zaka Friday, 20 October 2017

PP-140Drug design and DNA docking studies of the potential antitumor

Platinum(II) drugsRabia El-Hag Friday, 20 October 2017

PP-141

Computer-Aided Drug Design Experiments

on Apoptosis Regulator Bcl-2 Ümit Yılmaz Friday, 20 October 2017

PP-142Generation of Virtual Molecular Libraries by Using Unusual

Fragments for Lead Identification ISMAIL HAKKI AKGUN Friday, 20 October 2017

PP-143 A Virtual Screening Study To Discover Novel CB-1 Ligands Duhan Kılıçkan Friday, 20 October 2017

PP-144Identifying Novel Inhibitors of NF-Kb/Ikba Complex via Fragment-

Based e-Pharmacophore Drug ScreeningTarek Kanan Friday, 20 October 2017